Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Population Health | 3 | 2024 | 55 | 1.790 |
Why?
|
| Pharmacogenetics | 5 | 2024 | 264 | 1.310 |
Why?
|
| Genomics | 15 | 2024 | 2817 | 1.100 |
Why?
|
| Laboratories | 3 | 2024 | 138 | 0.860 |
Why?
|
| Computer Security | 1 | 2019 | 42 | 0.670 |
Why?
|
| Genetic Testing | 6 | 2021 | 1668 | 0.630 |
Why?
|
| Medical Records | 1 | 2019 | 443 | 0.610 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 5438 | 0.520 |
Why?
|
| Proteins | 7 | 2013 | 2047 | 0.490 |
Why?
|
| Genome, Human | 6 | 2021 | 1834 | 0.450 |
Why?
|
| Neptune | 1 | 2021 | 6 | 0.390 |
Why?
|
| Databases, Protein | 6 | 2015 | 101 | 0.320 |
Why?
|
| Protein Conformation | 5 | 2015 | 1280 | 0.310 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 2280 | 0.300 |
Why?
|
| Electronic Health Records | 4 | 2023 | 965 | 0.280 |
Why?
|
| Evolution, Molecular | 6 | 2015 | 864 | 0.280 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 565 | 0.280 |
Why?
|
| Sequence Analysis, Protein | 3 | 2015 | 80 | 0.260 |
Why?
|
| Software | 5 | 2021 | 1361 | 0.260 |
Why?
|
| Computational Biology | 5 | 2020 | 1263 | 0.230 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 38 | 0.230 |
Why?
|
| Genetics, Medical | 2 | 2021 | 140 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 2335 | 0.220 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2023 | 88 | 0.200 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 43 | 0.200 |
Why?
|
| Precision Medicine | 3 | 2024 | 1201 | 0.190 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 149 | 0.180 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2020 | 9 | 0.180 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 41 | 0.170 |
Why?
|
| Whole Genome Sequencing | 1 | 2022 | 360 | 0.170 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 230 | 0.170 |
Why?
|
| Pancreatitis | 1 | 2022 | 292 | 0.170 |
Why?
|
| United States | 5 | 2024 | 15983 | 0.170 |
Why?
|
| Gastritis | 1 | 2022 | 406 | 0.160 |
Why?
|
| Medical Informatics | 1 | 2021 | 191 | 0.160 |
Why?
|
| Enzymes | 4 | 2013 | 72 | 0.150 |
Why?
|
| Molecular Sequence Annotation | 3 | 2013 | 194 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 207 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2020 | 221 | 0.150 |
Why?
|
| Genetic Variation | 3 | 2021 | 2087 | 0.150 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 248 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 480 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2018 | 265 | 0.130 |
Why?
|
| Exome | 1 | 2021 | 1248 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 945 | 0.130 |
Why?
|
| Cardiology | 1 | 2021 | 573 | 0.130 |
Why?
|
| Exons | 1 | 2019 | 1379 | 0.120 |
Why?
|
| Humans | 23 | 2024 | 270947 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 1014 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 413 | 0.110 |
Why?
|
| Seizures | 1 | 2020 | 1048 | 0.110 |
Why?
|
| Pharmacogenomic Testing | 2 | 2024 | 46 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 1065 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 4327 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1543 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2013 | 183 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 6465 | 0.100 |
Why?
|
| Biochemistry | 1 | 2010 | 23 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2021 | 9433 | 0.090 |
Why?
|
| Algorithms | 5 | 2013 | 3910 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2010 | 221 | 0.090 |
Why?
|
| Proteome | 2 | 2013 | 572 | 0.090 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 1460 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2010 | 1070 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2020 | 2562 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2010 | 1080 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 6172 | 0.070 |
Why?
|
| Genotype | 2 | 2024 | 4109 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2010 | 1150 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2024 | 48 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2024 | 130 | 0.060 |
Why?
|
| Proteomics | 1 | 2010 | 1435 | 0.050 |
Why?
|
| Penetrance | 1 | 2023 | 127 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2023 | 68 | 0.050 |
Why?
|
| Health Level Seven | 1 | 2021 | 3 | 0.050 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 21 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 438 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 1153 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 153 | 0.040 |
Why?
|
| Computer Communication Networks | 1 | 2018 | 50 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 691 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 420 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2024 | 1773 | 0.040 |
Why?
|
| Polyps | 1 | 2018 | 83 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 16 | 0.040 |
Why?
|
| Connectin | 1 | 2017 | 28 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2017 | 39 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 455 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2017 | 104 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 124 | 0.040 |
Why?
|
| Acute Disease | 1 | 2022 | 2515 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 236 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 1069 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 155 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 1404 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1983 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2023 | 13352 | 0.030 |
Why?
|
| Base Sequence | 1 | 2022 | 5496 | 0.030 |
Why?
|
| Prevalence | 1 | 2023 | 3420 | 0.030 |
Why?
|
| Colon | 1 | 2018 | 689 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 15849 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2017 | 557 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 109 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2013 | 42 | 0.030 |
Why?
|
| Male | 5 | 2022 | 128454 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 846 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 279 | 0.030 |
Why?
|
| Myocardium | 1 | 2017 | 1249 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 809 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 582 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 1467 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2009 | 40 | 0.020 |
Why?
|
| Forecasting | 1 | 2013 | 707 | 0.020 |
Why?
|
| Adult | 3 | 2023 | 81555 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 2123 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 6837 | 0.020 |
Why?
|
| Female | 4 | 2022 | 148509 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 1091 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 885 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 1094 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 4399 | 0.020 |
Why?
|
| Phylogeny | 1 | 2009 | 866 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5904 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 17824 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 1758 | 0.020 |
Why?
|
| Internet | 1 | 2009 | 698 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 16978 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 90021 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 22059 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 32577 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 62771 | 0.010 |
Why?
|
| Child | 1 | 2017 | 30418 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 15854 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 73161 | 0.010 |
Why?
|